Receptor group

D2-like dopamine receptors

3 related receptors and the ligands measured at several of them.

Binding affinity (Kᵢ)

18 ligands measured at two or more members, human values in nM, strongest first. Select a value for its assay and source.

View
LigandD2 receptorD3 receptorD4 receptor
AL-LAD
LSD
ETH-LAD
5-MeO-DMT
Psilocin
Mescaline
Methylone
2C-E
2C-B
2C-Pnot measured
5-MeO-MiPT
2C-Inot measured
DMT
4-HO-METnot measured
DOI
DOB
2C-Cnot measured
2C-Dnot measured
Bufoteninnot measurednot measured
AL-LAD at D2: Kᵢ 270 nM, Jain et al. 2025AL-LAD at D3: Kᵢ 27 nM, Jain et al. 2025AL-LAD at D4: Kᵢ 150 nM, Jain et al. 2025LSD at D2: Kᵢ 39 nM, other reports differ, Janowsky et al. 2014LSD at D3: Kᵢ 27 nM, other reports differ, Janowsky et al. 2014LSD at D4: Kᵢ 330 nM, Janowsky et al. 2014ETH-LAD at D2: Kᵢ 160 nM, Jain et al. 2025ETH-LAD at D3: Kᵢ 81 nM, Jain et al. 2025ETH-LAD at D4: Kᵢ 240 nM, Jain et al. 20255-MeO-DMT at D2: Kᵢ 3562 nM, Ray 20105-MeO-DMT at D3: Kᵢ 498 nM, Ray 20105-MeO-DMT at D4: Kᵢ 3120 nM, Ray 2010Psilocin at D2: Kᵢ 3700 nM, Rickli et al. 2016Psilocin at D3: Kᵢ 910 nM, other reports differ, Jain et al. 2025Psilocin at D4: Kᵢ 1700 nM, Jain et al. 2025Mescaline at D2: Kᵢ 300 nM, Jain et al. 2025Mescaline at D4: Kᵢ 460 nM, Jain et al. 2025Mescaline at D3: Kᵢ of 10 µM or weakerMethylone at D3: Kᵢ 460 nM, Jain et al. 2025Methylone at D4: Kᵢ 1100 nM, Jain et al. 2025Methylone at D2: Kᵢ of 10 µM or weaker2C-E at D2: Kᵢ 3200 nM, Rickli et al. 20152C-E at D3: Kᵢ 1345 nM, Ray 20102C-E at D4: Kᵢ of 10 µM or weaker2C-B at D2: Kᵢ 2200 nM, Rickli et al. 20152C-B at D3: Kᵢ 7116 nM, Ray 20102C-B at D4: Kᵢ of 10 µM or weaker2C-P at D2: Kᵢ 2300 nM, Rickli et al. 20152C-P at D3: Kᵢ 5200 nM, Rickli et al. 20155-MeO-MiPT at D3: Kᵢ 2470 nM, Ray 20105-MeO-MiPT at D4: Kᵢ 6331 nM, Ray 20105-MeO-MiPT at D2: Kᵢ of 10 µM or weaker2C-I at D2: Kᵢ 2700 nM, Rickli et al. 20152C-I at D3: Kᵢ 5000 nM, Rickli et al. 2015DMT at D2: Kᵢ 3000 nM, Rickli et al. 2016DMT at D3: Kᵢ 6300 nM, Rickli et al. 2016DMT at D4: Kᵢ of 10 µM or weaker4-HO-MET at D2: Kᵢ 4000 nM, Rickli et al. 20164-HO-MET at D3: Kᵢ 6700 nM, Rickli et al. 2016DOI at D3: Kᵢ 690 nM, Jain et al. 2025DOI at D2: Kᵢ of 10 µM or weakerDOI at D4: Kᵢ of 10 µM or weakerDOB at D3: Kᵢ 808 nM, Ray 2010DOB at D2: Kᵢ of 10 µM or weakerDOB at D4: Kᵢ of 10 µM or weaker2C-C at D2: Kᵢ 2100 nM, Rickli et al. 20152C-C at D3: Kᵢ of 10 µM or weaker2C-D at D2: Kᵢ 7100 nM, Rickli et al. 20152C-D at D3: Kᵢ of 10 µM or weakerBufotenin at D3: Kᵢ 690 nM, Jain et al. 2025D2 receptorD2D3 receptorD3D4 receptorD4AL-LAD, Kᵢ: D2 270 nM, D3 27 nM, D4 150 nMAL-LADLSD, Kᵢ: D2 39 nM, D3 27 nM, D4 330 nMLSDETH-LAD, Kᵢ: D2 160 nM, D3 81 nM, D4 240 nMETH-LAD5-MeO-DMT, Kᵢ: D2 3562 nM, D3 498 nM, D4 3120 nM5-MeO-DMTPsilocin, Kᵢ: D2 3700 nM, D3 910 nM, D4 1700 nMPsilocinMescaline, Kᵢ: D2 300 nM, D3 10 µM or weaker, D4 460 nMMescalineMethylone, Kᵢ: D2 10 µM or weaker, D3 460 nM, D4 1100 nMMethylone2C-E, Kᵢ: D2 3200 nM, D3 1345 nM, D4 10 µM or weaker2C-E2C-B, Kᵢ: D2 2200 nM, D3 7116 nM, D4 10 µM or weaker2C-B2C-P, Kᵢ: D2 2300 nM, D3 5200 nM2C-P5-MeO-MiPT, Kᵢ: D2 10 µM or weaker, D3 2470 nM, D4 6331 nM5-MeO-MiPT2C-I, Kᵢ: D2 2700 nM, D3 5000 nM2C-IDMT, Kᵢ: D2 3000 nM, D3 6300 nM, D4 10 µM or weakerDMT4-HO-MET, Kᵢ: D2 4000 nM, D3 6700 nM4-HO-METDOI, Kᵢ: D2 10 µM or weaker, D3 690 nM, D4 10 µM or weakerDOIDOB, Kᵢ: D2 10 µM or weaker, D3 808 nM, D4 10 µM or weakerDOB2C-C, Kᵢ: D2 2100 nM, D3 10 µM or weaker2C-C2C-D, Kᵢ: D2 7100 nM, D3 10 µM or weaker2C-DBufotenin, Kᵢ: D3 690 nMBufotenin
stronger weaker other reports differ 10 µM or weaker (when shown)no line not measured or filtered out, not “inactive”

Lines connect each ligand to the members it has a displayed human Kᵢ at. The thicker and darker the line, the stronger the value. A ligand sits close to the members it binds most strongly and between those it binds about equally, so its position is only approximate. Select a ligand or a member to follow its lines, or a line to see its assay and source. The table view lists the same values.

stronger weaker≥ 10 µM measured, 10 µM or weakerempty not measured* other reports differ† source not traced to the original

Human values only. A cell shows the value displayed on the compound page, from one assay. Values from different assays are not directly interchangeable, and a value does not establish clinical potency or safety.